文献速递焦虑、强迫与应激相关障碍心境障碍

二甲双胍经mPFC抑制性神经元AMPK激活发挥抗焦虑作用

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons.
PubMed 文献 · Mol Psychiatry · 2023-10-05

研究基于糖尿病患者的临床观察与小鼠实验,探讨二甲双胍抗焦虑的机制。发现焦虑使mPFC的AMPK活性区域性降低,二甲双胍或AMPK过表达可恢复AMPK活性并减轻社会应激所致焦虑样行为,而mPFC或GABA能神经元特异性敲除AMPK则诱发焦虑并取消二甲双胍的抗焦虑效应。

要点

  • 焦虑诱导mPFC的AMPK活性区域性降低,脑特异性AMPK敲除小鼠出现异常焦虑样行为。
  • 二甲双胍或AMPK过表达恢复mPFC的AMPK活性,减轻社会应激诱导的焦虑样行为。
  • mPFC特异性敲除AMPK既诱发焦虑,也取消二甲双胍的抗焦虑作用。

核心结论

  • 二甲双胍的抗焦虑效应由内侧前额叶皮层(mPFC)抑制性神经元的AMPK激活所介导。

研究设计与样本

  • 研究为基于小鼠模型的实验研究,结合糖尿病患者的临床观察与转基因小鼠、脑片电生理记录。
  • 使用脑特异性AMPK敲除小鼠、mPFC特异性AMPK敲除小鼠及GABA能神经元特异性AMPK敲除小鼠。
  • 采用社会应激诱导焦虑样行为模型,并给予二甲双胍处理或AMPK过表达干预。

主要发现

  • 焦虑诱导mPFC的AMPK活性区域性降低,脑特异性AMPK敲除小鼠表现出异常焦虑样行为。
  • 二甲双胍或AMPK过表达恢复mPFC的AMPK活性,并减轻社会应激诱导的焦虑样行为。
  • mPFC特异性敲除AMPK既引发小鼠焦虑,也取消二甲双胍的抗焦虑效应。
  • 应激小鼠mPFC锥体神经元的GABA能兴奋及抑制性输入选择性减弱,导致兴奋-抑制失衡。
  • mPFC敲除AMPK导致类似的GABA能抑制性传递缺陷及锥体神经元抑制不足;GABA能神经元特异性AMPK敲除小鼠出现焦虑样行为。

临床怎么用

  • 结果提示二甲双胍可能作为焦虑障碍的潜在治疗选择,其作用依赖mPFC抑制性神经元的AMPK激活。
  • mPFC抑制性神经元AMPK及GABA能抑制性传递可作为焦虑机制研究与干预的潜在靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic patients receiving the antidiabetic drug metformin have been observed to exhibit a lower prevalence of anxiety disorders, yet the precise mechanism behind this phenomenon is unclear. In our study, we found that anxiety induces a region-specific reduction in AMPK activity in the medial prefrontal cortex (mPFC). Concurrently, transgenic mice with brain-specific AMPK knockout displayed abnormal anxiety-like behaviors. Treatment with metformin or the overexpression of AMPK restored normal AMPK activity in the mPFC and mitigated social stress-induced anxiety-like behaviors. Furthermore, the specific genetic deletion of AMPK in the mPFC not only instigated anxiety in mice but also nullified the anxiolytic effects of metformin. Brain slice recordings revealed that GABAergic excitation and the resulting inhibitory inputs to mPFC pyramidal neurons were selectively diminished in stressed mice. This reduction led to an excitation-inhibition imbalance, which was effectively reversed by metformin treatment or AMPK overexpression. Moreover, the genetic deletion of AMPK in the mPFC resulted in a similar defect in GABAergic inhibitory transmission and a consequent hypo-inhibition of mPFC pyramidal neurons. We also generated a mouse model with AMPK knockout specific to GABAergic neurons. The anxiety-like behaviors in this transgenic mouse demonstrated the unique role of AMPK in the GABAergic system in relation to anxiety. Therefore, our findings suggest that the activation of AMPK in mPFC inhibitory neurons underlies the anxiolytic effects of metformin, highlighting the potential of this primary antidiabetic drug as a therapeutic option for treating anxiety disorders.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Zhang YM, Zong HC, Qi YB, et al. Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons. Mol Psychiatry. 2023. PMID: 37798418. doi:10.1038/s41380-023-02283-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。